U.S., Nov. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07250321) titled 'Efficacy of tDCS in Degenerative Ataxia' on Nov. 18.
Brief Summary: Degenerative cerebellar ataxias are a group of rare diseases that cause gradual damage to the cerebellum, the part of the brain that controls balance and coordination. People with these conditions may have difficulty walking, keeping their balance, or coordinating movements. They may also experience vision problems, muscle stiffness, tremors, or changes in behavior, depending on the specific cause of the disease.
These disorders can greatly affect independence and quality of life, and unfortunately, there are currently no treatments that can stop or reverse the dis...